| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $21.4M | +86.9% |
| SG&A Expense | $11.9M | -2.7% |
| Operating Income | -$33.3M | -25.4% |
| Interest Expense | $24K | -25.6% |
| Net Income | -$33.8M | -32.9% |
| EPS (Basic) | -$1.04 | -11.8% |
| EPS (Diluted) | -$1.04 | -11.8% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.2M | -56.2% |
| Current Assets | $24.6M | -55.1% |
| Total Assets | $32.7M | -49.0% |
| Current Liabilities | $4.2M | -0.7% |
| Total Liabilities | $9.5M | -5.9% |
| Stockholders' Equity | $23.2M | -57.1% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.0M | -53.7% |
| Capital Expenditures | $472K | -67.2% |
| Investing Cash Flow | -$472K | +81.6% |
| Financing Cash Flow | -$257K | -100.6% |
| Free Cash Flow | -$29.5M | -45.2% |